| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/17/2008 | WO2008044379A1 Bone loss model animal |
| 04/17/2008 | WO2008044358A1 Primer set for detection of saccharomyces yeast |
| 04/17/2008 | WO2008044351A1 Novel transporter protein in mammal, and use thereof |
| 04/17/2008 | WO2008044213A1 Amiotropic lateral sclerosis (als) biomarkers and uses thereof |
| 04/17/2008 | WO2008044138A1 Optical nanosensor for detection of reactive oxygen species |
| 04/17/2008 | WO2008044129A2 Double-stranded probes for the fluorescent detection of nucleic acids |
| 04/17/2008 | WO2008044028A2 Labelling groups |
| 04/17/2008 | WO2008043987A2 Methods for amplifying and detecting nucleic acid sequences |
| 04/17/2008 | WO2008043725A1 Biomarker in inflammatory disorders |
| 04/17/2008 | WO2008043566A2 Compositions and methods for treating and diagnosing irritable bowel syndrome |
| 04/17/2008 | WO2008043543A2 Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology |
| 04/17/2008 | WO2008043525A1 Compositions and methods for therapy and diagnosis of cancer and cancer metastasis |
| 04/17/2008 | WO2008043521A2 Microrna (mirna) for the diagnosis and treatment of heart diseases |
| 04/17/2008 | WO2008043426A2 Components and method for enzymatic synthesis of nucleic acids |
| 04/17/2008 | WO2008043185A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 04/17/2008 | WO2008043153A1 A method of diagnosis and agents useful for same |
| 04/17/2008 | WO2008021290A8 Organ-specific proteins and methods of their use |
| 04/17/2008 | WO2008020364A3 Biochemical sensor device |
| 04/17/2008 | WO2008019861A3 Method for dissolving charged nucleic acid in an organic liquid |
| 04/17/2008 | WO2008017636A3 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 04/17/2008 | WO2008009732A3 Combinations of markers for increased accuracy of diagnosis of rheumatoid arthritis |
| 04/17/2008 | WO2008009365A3 A method for determining the methylation rate of a nucleic acid |
| 04/17/2008 | WO2007142936A3 Prediction of lung cancer tumor recurrence |
| 04/17/2008 | WO2007113388A3 Method and microarray for detecting herpesviruses |
| 04/17/2008 | WO2007100412A3 Methods and compositions related to the modulation of riboswitches |
| 04/17/2008 | WO2007095108A3 Isolated luciferase gene of l. italica |
| 04/17/2008 | WO2007094027A3 Methods for the diagnosis of proliferative and/or conformational diseases |
| 04/17/2008 | WO2007078850A3 Molecular diagnostics amplification system and methods |
| 04/17/2008 | WO2007070572A3 Probe for nucleic acid sequencing and methods of use |
| 04/17/2008 | WO2007070381A3 Nucleic acid purification with a binding matrix |
| 04/17/2008 | WO2007002654A8 Lxr ligand testing method |
| 04/17/2008 | WO2006137751A3 Methods, uses and compositions for detection of increased or decreased predisposition to various cancers by identification of specific genotypes of cyp1b1 gene |
| 04/17/2008 | US20080092251 Expression vector comprising nucleotide sequences coding oxidoreductase for enhancing oil production in transgenic crops |
| 04/17/2008 | US20080091004 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091003 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091002 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/17/2008 | US20080091001 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080090959 Epoxide polymer surfaces |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090776 Obtained from lung cancer patients; cDNA and genomic DNA of a novel fusion polynucleotide of an EML4 gene fused with an ALK gene as kinase (EML4-ALK fusion polynucleotide variant 1); for screening a therapeutic agent for cancer, treating cancer |
| 04/17/2008 | US20080090763 Novel gene encoding a dna repair enzyme and methods of use thereof |
| 04/17/2008 | US20080090759 Methods and kits for predicting risk for preterm labor |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090738 Authentication of biologic materials using dna-dna hybridization on a solid support |
| 04/17/2008 | US20080090737 Methods for reducing the range in concentrations of analyte species in a sample |
| 04/17/2008 | US20080090733 Method for selectively isolating a nucleic acid |
| 04/17/2008 | US20080090268 Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method |
| 04/17/2008 | US20080090267 Dispensing fluids onto viable tissues/cells individually; contacting thin-film with tissue and using ink-jet to dispense fluid onto thin film, using flim to discharge microvolumes of solution onto cells |
| 04/17/2008 | US20080090266 Method of Selecting a Cardiomyoctye Using Intracellular Mitochondria as an Indicator |
| 04/17/2008 | US20080090265 Method to Assay Coenzzyme Q10 in Blood Plasma or Blood Serum |
| 04/17/2008 | US20080090264 Devices and methods for profiling enzyme substrates |
| 04/17/2008 | US20080090263 Two secretory luciferases |
| 04/17/2008 | US20080090261 Method For The In Vitro Diagnosis Of The Exclusion Of Acute Coronary Syndromes |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080090252 Using neutrophil degranulation as diagnostic indicator of respiratory stystem disorders |
| 04/17/2008 | US20080090248 Surface-plasmon resonance-based methods for identifying kinases and their substrates |
| 04/17/2008 | US20080090247 Identifying RNA analyte using 2'-O-methyl ribonucleotide probes; nucleic acid hybridization analysis for use in medical and veterinary diagnostics, food testing and forensics |
| 04/17/2008 | US20080090246 Using 2'-O-methyl ribonucleotide probes as tool in identifying and replicating preferential transcription products; enhanced probe recoginition of target analytes |
| 04/17/2008 | US20080090245 Diagnosing and Treating Hematopoietic Cancers |
| 04/17/2008 | US20080090244 Using multiple probes hybridization to determine size of preferential nucleotide sequences |
| 04/17/2008 | US20080090243 Clonal population of cells embedded in paraffin block for use as sample source in histological analysis |
| 04/17/2008 | US20080090242 Farnesyl protein transferase inhibitors (FTI); anticancer agents |
| 04/17/2008 | US20080090241 Using primer amplification to identify lepidopteran insect resistant cotton; biological pest control |
| 04/17/2008 | US20080090240 Neisseria gonorrhoeae specific oligonucleotide sequences |
| 04/17/2008 | US20080090239 Using morphological and molecular variation in cells as evaluative tools in diagnosis and prognosis of cancer |
| 04/17/2008 | US20080090238 Increased sensitivity of proximity ligation assays |
| 04/17/2008 | US20080090237 Methods and compositions for comparing chromosomal copy number between genomic samples |
| 04/17/2008 | US20080090236 Using chromosomal aberration as evaluative tool in diagnosing and prognosing cell proliferative disorders |
| 04/17/2008 | US20080090235 Unstructured nucleic acid PCR primers and methods of using the same |
| 04/17/2008 | US20080090234 Diagnostic assay for autoimmune lymphoproliferative syndrome (ALPS) and genetically related disorders |
| 04/17/2008 | US20080090233 Methods for Prediction of Clinical Outcome to Epidermal Growth Factor Receptor Inhibitors by Cancer Patients |
| 04/17/2008 | US20080090232 Devices for generating detectable polymers |
| 04/17/2008 | US20080090231 Apparatus which utilizes cyclic amplification of biopolymer sequences to detect coronaviral polynucleotides |
| 04/17/2008 | US20080090230 Devices for generating detectable polymers |
| 04/17/2008 | US20080090229 Devices for generating detectable polymers |
| 04/17/2008 | US20080090228 Devices for generating detectable polymers |
| 04/17/2008 | US20080090227 Using restricted ranges of temperature and relative humidity as tools in enhancing deposition and dispersment of chromosomal material on slides; cytogenetics and disease diagnosis; karyotyping |
| 04/17/2008 | US20080090226 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080090225 Using virally infected mammalian cells as models for screening viricidal agents; drug screening |
| 04/17/2008 | US20080090224 Nucleic acid detection |
| 04/17/2008 | US20080090223 Using presense of apolipoprotein isoforms as evaluative tool in diagnosing liver and cell proliferative disorders |
| 04/17/2008 | US20080089909 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089899 Streptococcus pneumoniae proteins and nucleic |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089884 For treating and/or preventing bladder disorders; for decreasing the expression, release or biological activity of macrophage migration inhibition factor |
| 04/17/2008 | US20080089881 Using nicotinic acid receptor (HM74) as diagnostic and evaluative tool in detection of psoraisis, ulcerative colitis, multiple sclerosis, irratable bowel and/or , crohn's diseases |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089872 Method for purifying pluri-differentiated mesenchymal progenitor cells |
| 04/17/2008 | US20080089862 Serine protease inhibitor for prevention and treatment of cell proliferative, liver and inflammatory disorders |
| 04/17/2008 | US20080088308 Methods of In Vitro Analysis Using Time-Domain Nmr Spectroscopy |
| 04/17/2008 | US20080087543 Biosensor |
| 04/17/2008 | DE19948087B4 Verfahren zur Herstellung eines Reaktionssubstrats A method for producing a substrate reaction |
| 04/17/2008 | DE112005003134T5 Elektrisch aktiver kombinatorisch-chemischer (electrically-active combinatorial-chemical; eacc) Chip zur biochemischen Analytbestimmung Electrically active combinatorial chemistry (electrically-active combinatorial-chemical; EACC) chip for biochemical analyte |
| 04/17/2008 | DE102006048693A1 Inhibition der PDE2A Inhibition of PDE2A |
| 04/17/2008 | DE102006048201A1 Autoantigene zur verbesserten Diagnose, Prognose und Therapie von entzündlichen neurologischen Erkrankungen Autoantigens for the improved diagnosis, prognosis and therapy of inflammatory neurological disorders |
| 04/17/2008 | CA2791144A1 Protease screening methods and proteases identified thereby |
| 04/17/2008 | CA2713101A1 Method for a continuous rapid thermal cycle system |
| 04/17/2008 | CA2668818A1 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |